108 related articles for article (PubMed ID: 909109)
1. Mycobacterium bovis (BCG) infection of the lymph nodes of normal, immune, and cortisone-treated guinea pigs.
Collins FM; Auclair L; Mackaness GB
J Natl Cancer Inst; 1977 Nov; 59(5):1527-35. PubMed ID: 909109
[TBL] [Abstract][Full Text] [Related]
2. Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.
Derrick SC; Yang A; Parra M; Kolibab K; Morris SL
Vaccine; 2015 Jan; 33(1):126-32. PubMed ID: 25448108
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig.
Hanna MG; Peters LC; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1976 May; 56(5):1013-7. PubMed ID: 186611
[TBL] [Abstract][Full Text] [Related]
4. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice.
Jeevan A; Kripke ML
J Immunol; 1989 Nov; 143(9):2837-43. PubMed ID: 2681417
[TBL] [Abstract][Full Text] [Related]
5. Cellular oxidative responses and mycobacterial growth inhibition in aerosol and intradermal BCG-immunized guinea-pigs.
Lagranderie M; Frehel C; de Chastellier C; Gheorghiu M
Biologicals; 1991 Oct; 19(4):335-45. PubMed ID: 1665701
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG).
Zbar B; Hunter JT; Rapp HJ; Canti GF
J Natl Cancer Inst; 1978 May; 60(5):1163-8. PubMed ID: 642033
[TBL] [Abstract][Full Text] [Related]
7. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
Smith HG; Bast RC; Zbar B; Rapp HJ
J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
[TBL] [Abstract][Full Text] [Related]
9. Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.
van der Meijden AP; de Jong WH; de Boer EC; Steerenberg PA; Debruyne FM; Ruitenberg EJ
Urol Res; 1989; 17(1):47-55. PubMed ID: 2922891
[TBL] [Abstract][Full Text] [Related]
10. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
[TBL] [Abstract][Full Text] [Related]
11. Response to Mycobacterium bovis BCG vaccination in protein- and zinc-deficient guinea pigs.
McMurray DN; Yetley EA
Infect Immun; 1983 Feb; 39(2):755-61. PubMed ID: 6339390
[TBL] [Abstract][Full Text] [Related]
12. Intradermal BCG infection in the guinea-pig. 2. Dispersion to regional lymph nodes within the first day of infection.
WETTELAND P; VOGELSANG TM
Acta Pathol Microbiol Scand Suppl; 1961; Suppl 148():207-18. PubMed ID: 13784655
[No Abstract] [Full Text] [Related]
13. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
14. Intradermal BCG infection in the guinea-pig. 1. Dispersion to regional lymph nodes and spleen within the first week of infection.
WETTELAND P; VOGELSANG TM
Acta Pathol Microbiol Scand Suppl; 1961; Suppl 148():197-206. PubMed ID: 13784654
[No Abstract] [Full Text] [Related]
15. Restoration of T-cell responsiveness by thymosin: expression of anti-tuberculous immunity in mouse lungs.
Collins FM; Morrison NE
Infect Immun; 1979 Feb; 23(2):330-5. PubMed ID: 154473
[TBL] [Abstract][Full Text] [Related]
16. Intravesical BCG administration in the guinea pig. Histomorphological aspects.
van der Meijden AP; de Jong WH; Steerenberg PA; Debruyne FM; Ruitenberg JE
Prog Clin Biol Res; 1989; 310():67-79. PubMed ID: 2672024
[No Abstract] [Full Text] [Related]
17. Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig.
de Boer EC; Steerenberg PA; van der Meijden AP; van Klingeren B; de Jong WH; Debruyne FM; Ruitenberg EJ
Prog Clin Biol Res; 1992; 378():81-93. PubMed ID: 1301589
[TBL] [Abstract][Full Text] [Related]
18. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis.
Corner LA; Costello E; O'Meara D; Lesellier S; Aldwell FE; Singh M; Hewinson RG; Chambers MA; Gormley E
Vaccine; 2010 Aug; 28(38):6265-72. PubMed ID: 20637774
[TBL] [Abstract][Full Text] [Related]
19. Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge.
Shepard CC; Walker LL; Van Landingham RM
Infect Immun; 1978 Feb; 19(2):391-4. PubMed ID: 344208
[TBL] [Abstract][Full Text] [Related]
20. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
